Clinical Research Directory

Inclusion Criteria: * Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines; * Age over 18 years; * Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks; * Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT) * Have a smartphone compatible with the monitoring device; * Signing of the ICF to participate in the study. Exclusion Criteria: * Presence of other concomitant lung diseases; * Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated. * Patients who received a lung transplant during the study * Living outside the coverage area or moving out of state